Americana Partners
ATRA icon

Americana Partners’s Atara Biotherapeutics ATRA Stock Holding History

Americana Partners’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-820
Closed -$323K – 235
2021
Q4 		$323K Buy
820
+299
+57% +$126K 0.06% 199
2021
Q3 		$233K Buy
+521
New +$187K 0.06% 217

Other funds holding ATRA

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Baupost Group
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Americana Partners's ATRA Position: Q1 2022 in Review

Americana Partners sold out of Atara Biotherapeutics (ATRA) in Q1 2022, closing a stake of 820 shares — an estimated $323K sold.

Americana Partners first reported a position in ATRA in Q3 2021 and held it in 2 quarters. The position peaked at $323K in Q4 2021. 144 funds tracked by Wall St. Rank hold ATRA as of Q1 2022.

  • Americana Partners reported no remaining Atara Biotherapeutics position as of Q1 2022 after selling out during the quarter.
  • Americana Partners sold 820 Atara Biotherapeutics shares in Q1 2022, an estimated $323K.
  • Americana Partners first reported a position in Atara Biotherapeutics in Q3 2021 and held it in 2 quarters.
  • Americana Partners's Atara Biotherapeutics position peaked at $323K in Q4 2021.
  • 144 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2022.

Based on Americana Partners's 13F filing for Q1 2022, filed 6 May 2022.